HPOL-B Stock Analysis: HEXPOL (publ) | ST
Specialty Chemicals | ST, Sweden | Market Cap: 29.932m SEK | 12M Return: 7.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.7M
EPS Trend: -98.2%
Qual. Beats: 0
Rev. Trend: -98.0%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HEXPOL AB (publ) is a Swedish specialty chemicals and engineered products manufacturer headquartered in Malmö, operating globally across Europe, the Americas, and Asia. The company runs two business segments: HEXPOL Compounding, which produces natural and synthetic rubber compounds, thermoplastic elastomer compounds, and thermoplastic compounds under brands such as HEXFLAME, Dryflex, Mediprene, and RheTech; and HEXPOL Engineered Products, which supplies finished gaskets and seals under the Gislaved Gummi brand and wheels under the Stellana brand. Founded in 1893 and formerly known as Hexagon Polymers AB before adopting its current name in May 2008, HEXPOL serves a broad B2B customer base spanning automotive, aerospace, energy, construction, oil and gas, medical equipment, and consumer products manufacturers.
As a mid-cap player in the specialty chemicals sub-industry within the Materials sector, HEXPOL follows a diversified industrial supplier model, distributing its polymer-based inputs and finished components across more than a dozen end markets, which reduces reliance on any single industry. Its dual structure of custom compounding and branded engineered products positions it as both a raw-materials provider to manufacturers and a producer of finished components, giving it exposure to both upstream and downstream value chains in rubber and plastics.
- Automotive demand softness pressures compounding segment volumes
- Raw material cost volatility squeezes polymer compound margins
- M&A pipeline expansion accelerates compounding segment growth
| Net Income: 1.83b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.74 > 1.0 |
| NWC/Revenue: -6.30% < 20% (prev -5.41%; Δ -0.89% < -1%) |
| CFO/TA 0.11 > 3% & CFO 2.81b > Net Income 1.83b |
| Net Debt (4.19b) to EBITDA (3.06b): 1.37 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (344.4m) vs 12m ago 0.0% < -2% |
| Gross Margin: 21.04% > 18% (prev 21.07%; Δ -0.02% > 0.5%) |
| Asset Turnover: 76.19% > 50% (prev 82.36%; Δ -6.18% > 0%) |
| Interest Coverage Ratio: 23.07 > 6 (EBIT TTM 2.47b / Interest Expense TTM 107.0m) |
| A: -0.05 (Total Current Assets 7.99b - Total Current Liabilities 9.19b) / Total Assets 25.5b |
| B: 0.46 (Retained Earnings 11.8b / Total Assets 25.5b) |
| C: 0.10 (EBIT TTM 2.47b / Avg Total Assets 24.9b) |
| D: 1.30 (Book Value of Equity 14.4b / Total Liabilities 11.1b) |
| Altman-Z'' = 3.22 = A |
| DSRI: 1.11 (Receivables 3.89b/3.69b, Revenue 19.0b/20.0b) |
| GMI: 1.00 (GM 21.07% / 21.04%) |
| AQI: 0.96 (AQ_t 0.54 / AQ_t-1 0.56) |
| SGI: 0.95 (Revenue 19.0b / 20.0b) |
| TATA: -0.04 (NI 1.83b - CFO 2.81b) / TA 25.5b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of July 29, 2026, the stock is trading at SEK 87.70 with a total of 294,998 shares traded. Over the past week, the price has changed by +4.03%, over one month by +22.74%, over three months by +17.50% and over the past year by +7.75%.
Current recommended Stop Loss: 84.40 (which is 3.8% or 1.5 ATR below the current price).
HEXPOL (publ) has no consensus analysts rating.
P/E Trailing = 16.3962
P/E Forward = 18.3824
P/S = 1.5758
P/B = 2.014
P/EG = 2.729
Revenue TTM = 19.0b SEK
EBIT TTM = 2.47b SEK
EBITDA TTM = 3.06b SEK
Long Term Debt = 338.0m SEK (from longTermDebtTotal, last fiscal year)
Short Term Debt = 5.03b SEK (from shortTermDebt, last quarter)
Debt = 5.80b SEK (from shortLongTermDebtTotal, last quarter) + Leases 428.0m
Net Debt = 4.19b SEK (calculated: Debt 5.80b - CCE 1.61b)
Enterprise Value = 34.1b SEK (29.9b + Debt 5.80b - CCE 1.61b)
Interest Coverage Ratio = 23.07 (Ebit TTM 2.47b / Interest Expense TTM 107.0m)
EV/FCF = 14.04x (Enterprise Value 34.1b / FCF TTM 2.43b)
FCF Yield = 7.12% (FCF TTM 2.43b / Enterprise Value 34.1b)
FCF Margin = 12.79% (FCF TTM 2.43b / Revenue TTM 19.0b)
Net Margin = 9.62% (Net Income TTM 1.83b / Revenue TTM 19.0b)
Gross Margin = 21.04% ((Revenue TTM 19.0b - Cost of Revenue TTM 15.0b) / Revenue TTM)
Gross Margin QoQ = 21.78% (prev 21.54%)
Tobins Q-Ratio = 1.34 (Enterprise Value 34.1b / Total Assets 25.5b)
Interest Expense / Debt = 1.84% (Interest Expense 107.0m / Debt 5.80b)
Taxrate = 27.40% (690.0m / 2.52b)
NOPAT = 1.79b (EBIT 2.47b * (1 - 27.40%))
Current Ratio = 0.87 (Total Current Assets 7.99b / Total Current Liabilities 9.19b)
Debt / Equity = 0.40 (Debt 5.80b / totalStockholderEquity, last quarter 14.4b)
Debt / EBITDA = 1.37 (Net Debt 4.19b / EBITDA 3.06b)
Debt / FCF = 1.72 (Net Debt 4.19b / FCF TTM 2.43b)
Total Stockholder Equity = 14.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.33% (Net Income 1.83b / Total Assets 25.5b)
RoE = 12.72% (Net Income TTM 1.83b / Total Stockholder Equity 14.4b)
RoCE = 16.78% (EBIT 2.47b / Capital Employed (Equity 14.4b + L.T.Debt 338.0m))
RoIC = 8.78% (NOPAT 1.79b / Invested Capital 20.4b)
WACC = 7.25% (E(29.9b)/V(35.7b) * Re(8.40%) + D(5.80b)/V(35.7b) * Rd(1.84%) * (1-Tc(0.27)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 49.75 | Cagr: 0.00%
[DCF] Terminal Value 77.75% ; FCFF base≈2.31b ; Y1≈2.62b ; Y5≈3.74b
[DCF] Fair Price = 158.5 (EV 56.5b - Net Debt 4.19b = Equity 52.3b / Shares 329.7m; r=8.35% [WACC [floored]]; 5y FCF grow 13.60% → 2.50% )
EPS Correlation: -98.17 | EPS CAGR: -13.42% | SUE: 0.76 | # QB: 0
Revenue Correlation: -98.05 | Revenue CAGR: -6.14% | SUE: 0.91 | # QB: 1
EPS current Quarter (2026-09-30): EPS=1.47 | Chg30d=+2.80% | Revisions=+25% | Analysts=4
EPS current Year (2026-12-31): EPS=5.71 | Chg30d=+2.88% | Revisions=+0% | GrowthEPS=+1.2% | GrowthRev=-0.0%
EPS next Year (2027-12-31): EPS=6.24 | Chg30d=+1.54% | Revisions=+0% | GrowthEPS=+9.2% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: +12% (up=3, down=2)